AMRA Medical Advises MRI-Based Muscle Assessment Technology Approved for Clinical Use in US and Canada

AMRA Medical, a ground-breaking digital health company and global leader in body composition analysis offering medical device and medical research services, announced today that AMRA has received 510(k) clearance from the FDA and MDEL (Medical Device Establishment Licence) licensing.

AMRA Medical is now permitted to distribute AMRA® BCP Scan (Body Composition Profile) in the US and Canada. The BCP Scan uses muscle and fat biomarkers from magnetic resonance imaging (MRI) scans to provide objective and actionable data to clinicians.

The AMRA® BCP Scan is offered as a medical device service to promote health and wellness. The technology utilizes AMRA’s rapid neck-to-knee MRI protocol, to produce an easy-to-understand and actionable patient-specific report. The report contains patient-specific body composition measurements, such as muscle, fat, and liver fat volumes, with a comparison to normative values based on AMRA’s reference database. The report goes further to compare the patient with others of the same sex and body habitus, making the results even more personalized. The body composition measurements derived from the MR images provide information that may promote healthy lifestyle choices. For instance, if the BCP Scan detects a high level of visceral fat—which is associated with a higher risk of type 2 diabetes and heart disease—a physician evaluating the results may decide to encourage a lifestyle change of his or her patient that has been shown to reduce visceral fat.

Eric Converse, CEO at AMRA, commented: “We are thrilled to expand this technology to the US and Canada. The AMRA® BCP Scan brings health assessment into a new era. Rather than relying on BMI or waist circumference, we have precise fat and muscle measurements so a physician can really see what is going on inside the body.” Converse continued: “Our protocol only adds minutes to an already prescribed MRI, and because we deliver the results through a simple report, clinicians and patients can easily understand the information and potentially use that information to make healthy lifestyle choices.”

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.